High prevalence of syringe sharing among street involved youth

Addiction Research and Theory

Volumn 16, Issue 4, 2008, Pages 353-358

  Lloyd Smith, Elisa ^a   Kerr, Thomas ^a   Zhang, Ruth ^a   Montaner, Julio S G ^a   Wood, Evan ^a  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

Author keywords

Injection drug use; Street involved youth; Syringe sharing

Indexed keywords

EID: 50149111760     PISSN: 16066359     EISSN: 14767392     Source Type: Journal    
DOI: 10.1080/16066350701823094     Document Type: Article

References (17)

1. Ball AL, Rana S, Dehne KL. 1998. HIV prevention among injecting drug users: Responses in developing and transitional countries. Public Health Report 113:170-181.
2. Bogart LM, Kral A, Scott A, Anderson R, Flynn N, Gilbert ML, Bluthenthal RN. 2005. Sexual risk among injection drug users recruited from syringe exchange programs in California. Sexually Transmitted Diseases 32:27-34.
3. Crofts N, Aitken CK, Kaldor JM. 1999. The force of numbers: Why hepatitis C is spreading among Australian injecting drug users while HIV is not. Medical Journal Of Australia 170:220-221.
4. Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D. 2000. Correlates of HIV infection among young adult short-term injection drug users. AIDS 14:717-726.
5. Epele ME. 2003. Changing Cocaine Use Practices: Neo-liberalism, HIV-AIDS, and Death in an Argentine Shantytown. Subst Use and Misuse 38:1189-1216.
6. Hurley SF, Jolley DJ, Kaldor JM. 1997. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 349:1797-1800.
7. Kerr T, Tyndall M, Li K, Montaner J, Wood E. 2005. Safer injection facility use and syringe sharing in injection drug users. Lancet 366:316-318.
8. Miller CL, Johnston C, Spittal PM, Li K, Laliberte N, Montaner JS, Schechter MT. 2002. Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 36:737-742.
9. Miller CL, Kerr T, Frankish JC, Spittal PM, Li K, Schechter MT, Wood E. 2006. Binge drug use independently predicts HIV seroconversion among injection drug users: Implications for public health strategies. Subst Use and Misuse 41:199-210.
10. Neaigus A, Friedman SR, Jose B, Goldstein MF, Curtis R, Ildefonso G, Des Jarlais DC. 1996. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. Journal of Acquired Immune Deficiency Syndromes 11:499-509.
11. Rhodes T, Mikhailova L, Sarang A, Lowndes CM, Rylkov A, Khutorskoy M, Renton A. 2003. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: A qualitative study of micro risk environment. Social Science and Medicine 57:39-54.
12. Sherman S, Latkin C, Gielen AC. 2001. Social factors related to syringe sharing among injecting partners: A focus on gender. Subst Use and Misuse 36:2113-2136.
13. Strathdee S, Vlahov D. 2001. The effectiveness of needle exchange programs: A review of the science and policy. AIDScience 1.
14. Tyndall MW, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy MV, Schechter MT. 2003. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 17:887-893.
15. Wood E, Stoltz JA, Montaner JS, Kerr T. 2006. Evaluating methamphetamine use and risks of injection initiation among street youth: The ARYS study. Harm Reduction Journal 3:1-33.
16. Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, Montaner JS, O'Shaughnessy MV, Schechter MT. 2001. Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help?. Canadian Medical Association Journal 165:405-410.
17. Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, Montaner JS, O'Shaughnessy MV, Schechter MT. 2002. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS 16:941-943.